DNAdose News -Summer Edition - Many doctors have written to us in the past year requesting we indicate when to request the test, and for which patients.
We would like to wish you, your family and staff best wishes for the holiday season and look forwards to assisting you in the New Year. Merry Xmas and our very best wishes for 2013.
DNAdose News Spring Edition - CYP2D6: Who do you think you are? Gene polymorphisms (variations in the gene) can give clues as to our historical ancestors
Announcement: Genes Fx is excited to announce it has received government funding to develop a pharmacogenomic decision support system will which be implemented at Melbourne Health hospitals. This will formally announced by the Minister for Innovation.
DNAdose News - Autumn - Pharmacogenomics Testing for Analgesics
Pain killers have been the focus of media attention in recent months as TV current affairs shows have highlighted those who get addicted to opioid analgesics resulting in life threatening and antisocial outcomes
Associate Professor Les Shefffield was honored to be asked to present to the Epworth on the topic of "Personalising prescribing using pharmacogenomic testing to individualise treatment for Epworth patients" at the Grand Rounds next Wednesday 13th May.
DNAdose News - Improving medication compliance
In this edition, we examine: the challenges of patient medication compliance, and how DNAdose improves patient conformity to prescribed medications; a case study, demonstrating the repercussions of untailored medicinal treatments; and the latest research on clopidogrel from the American Heart Association.
TPMT genotyping has become a Medicare item and to meet world's best practice a number of public hospitals in Victoria including the Royal Children's Hospital, have initialised Pharmacogenomic testing for their patients.
Health Benefits of Pharmacogenomics recognised in Victorian Government grant
We at GenesFX Health are proud to announce that GenesFX Health has been awarded a Victorian Government Grant to prepare for the introduction of pharmacogenomics into The Royal Melbourne Hospital’s clinical practice.
GPCE, MELBOURNE, AUSTRALIA, NOVEMBER 11-13TH OF NOVEMBER
We welcome you to come listen to a 1 hour education session at this years GPCE in Melbourne. Pharmacogenomics in General Practice – A New Approach to Personalised Medicine. Mr Sam Mostafa http://www.gpce.com.au/en/melbourne/events/meet-the-expert/
Welcome to our first DNAdose newsletter. Many doctors and patients have written and phoned me to say how incorporating Pharmacogenomics into their practice has improved their patients lives and assisted them in their medical practice.
In this edition, we look at the use of Pharmacogenomics in the treatment of depression. Consultant Pharmacist, Sam Mostafa discusses antidepressant medication selection and we share a DNAdose case studyof a patient who did not respond to citalopram.
The adoption of pharmacogenomics, the science of prescribing drugs based on an individual's biomarkers or genetic make-up, is far too slow. Biomarkers, which can be examined through a simple blood test, can tell a doctor whether a patient will have a good response to a drug, a poor response or no response at all.
The recurrence risk of cardiovascular events and death following clopidogrel treatment is associated with CYP2C19 genetic status.
Plavix (clopidogrel bisulfate) 75 mg tablets
Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- May 2009
Precautions detailed in relation to Pharmacogentics and Drug Interactions.